ketoconazole has been researched along with Candidiasis, Genital in 107 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy of ketoconazole was evaluated in forty-five patients with dermatophytoses, in twelve with candidosis, in two with fixed cutaneous sporotrichosis, in one with primary cutaneous cryptococcosis and in one with pulmonary aspergillosis." | 3.67 | Therapeutic experience with ketoconazole. ( Difonzo, EM; Palleschi, GM; Panconesi, E; Vannini, P, 1986) |
| " Here we present the results in the relief of vaginitis and vaginosis with two different dosage forms." | 2.76 | [Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis]. ( Bravo-Topete, EG; Cejudo-Alvarez, J; Garibay-Valencia, M; Herrera-Villalobos, JE; Martínez-García, A; Mirabent-González, F, 2011) |
| "Clinical recurrence of candida vaginitis with confirmation by smear and culture." | 2.67 | The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. ( Fong, IW, 1992) |
| " The feasibility of one-day therapy was assessed in a clinical study in which three different dosage regimens were compared in a total of 552 patients with acute vulvovaginal candidosis: 200 mg twice daily for one day; 200 mg once daily for two days; and 200 mg once daily for three days." | 2.67 | Itraconazole: a single-day oral treatment for acute vulvovaginal candidosis. ( Wesel, S, 1990) |
| " Two dosage regimens were tested--200 mg twice a day for 1 day and 200 mg twice a day for 2 days." | 2.66 | Itraconazole in the treatment of acute vaginal candidiasis. ( Barnard, PG; Bloch, B; Burger, GD; Meyer, JS; Parkes, JR; Smythe, E, 1988) |
| "Cure and recurrence rates were not different in the three treatment groups, with or without simultaneous treatment of the male partner." | 2.66 | Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study. ( Bisschop, MP; Merkus, JM; Scheygrond, H; van Cutsem, J, 1986) |
| "Vulvovaginal candidiasis is considered recurrent when at least four specific episodes occur in one year or at least three episodes unrelated to antibiotic therapy occur within one year." | 2.41 | Treatment of recurrent vulvovaginal candidiasis. ( Ringdahl, EN, 2000) |
| "that may contribute to recurrence can be eliminated at the same time." | 2.38 | Chronic vulvovaginal candidosis: the role of oral treatment. ( Merkus, JM; Van Heusden, AM, 1990) |
| "Fenticonazole was assessed by European Committee on Antimicrobial Susceptibility Testing and CLSI microdilution methods for the first time, and the results showed excellent agreement (97%) and significant interclass correlation coefficient (P < 0." | 1.35 | Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes. ( Alexopoulos, EC; Antonopoulou, S; Aoun, M; Baka, S; Grigoriou, O; Kalambokas, T; Kouskouni, E; Logothetis, E; Papadias, K; Velegraki, A; Zannos, A, 2009) |
| " Lipid granules of KTZ prepared with Compritol 888 ATO could be proposed as a new KTZ solid dosage form with optimum dissolution and therapeutic characteristics." | 1.34 | In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules. ( Ay, Z; Durmaz, G; Ertan, G; Gokce, EH; Gokce, G; Guneri, T; Hilmioglu, S; Metin, DY; Ozer, O; Ozyazici, M; Ozyurt, D; Pekcetin, C; Yalcin, A, 2007) |
| "Carbamazepine was of little benefit (13% response)." | 1.30 | Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia. ( Pagano, R, 1999) |
| "Although there is no explanation for recurrence in most cases of CRCV, intermittent treatment schedules can be used to treat but not to cure these patients." | 1.28 | Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant. ( Merkus, JM; van Heusden, AM, 1990) |
| " With a dosage regimen of 10 mg/kg by gavage for 5 days, the cure rate for ketoconazole was 96% as compared with rates of 23 and 29% for Bay N7133 and Bay L9139, respectively (P less than 0." | 1.27 | Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis. ( Muller, G; Sobel, JD, 1983) |
| "Vulvovaginal candidiasis is a monoetiologic disease, but the pathways by which pathogenic expression is attained are sufficiently divergent to constitute a classification schema that influences therapy." | 1.27 | Classification and pathogenesis of vulvovaginal candidiasis. ( Monif, GR, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 63 (58.88) | 18.7374 |
| 1990's | 26 (24.30) | 18.2507 |
| 2000's | 13 (12.15) | 29.6817 |
| 2010's | 4 (3.74) | 24.3611 |
| 2020's | 1 (0.93) | 2.80 |
| Authors | Studies |
|---|---|
| Heeres, J | 1 |
| Backx, LJ | 1 |
| Van Cutsem, J | 5 |
| Emmer, G | 1 |
| Grassberger, MA | 1 |
| Meingassner, JG | 2 |
| Schulz, G | 1 |
| Schaude, M | 1 |
| Antonopoulou, S | 1 |
| Aoun, M | 1 |
| Alexopoulos, EC | 1 |
| Baka, S | 1 |
| Logothetis, E | 1 |
| Kalambokas, T | 1 |
| Zannos, A | 1 |
| Papadias, K | 1 |
| Grigoriou, O | 1 |
| Kouskouni, E | 1 |
| Velegraki, A | 1 |
| Aslan Kayıran, M | 1 |
| Erdemir, AV | 1 |
| Dağdelen, D | 1 |
| Cebeci, F | 1 |
| Koçoğlu, E | 1 |
| Gürel, MS | 1 |
| Abd Ellah, NH | 1 |
| Abdel-Aleem, JA | 1 |
| Abdo, MN | 1 |
| Abou-Ghadir, OF | 1 |
| Zahran, KM | 1 |
| Hetta, HF | 1 |
| Herrera-Arellano, A | 2 |
| López-Villegas, EO | 1 |
| Rodríguez-Tovar, AV | 2 |
| Zamilpa, A | 2 |
| Jiménez-Ferrer, E | 2 |
| Tortoriello, J | 2 |
| Martínez-Rivera, MA | 1 |
| Martínez-Rivera, Mde L | 1 |
| Herrera-Alvarez, S | 1 |
| Salas-Andonaegui, ML | 1 |
| Nava-Xalpa, MY | 1 |
| Méndez-Salas, A | 1 |
| Zhang, H | 1 |
| Wang, K | 1 |
| Zhang, G | 1 |
| Ho, HI | 1 |
| Gao, A | 1 |
| Nikolov, A | 1 |
| Martínez-García, A | 1 |
| Cejudo-Alvarez, J | 1 |
| Bravo-Topete, EG | 1 |
| Herrera-Villalobos, JE | 1 |
| Garibay-Valencia, M | 1 |
| Mirabent-González, F | 1 |
| Marrazzo, J | 2 |
| Spence, D | 2 |
| Kendirci, M | 1 |
| Koç, AN | 1 |
| Kurtoglu, S | 1 |
| Keskin, M | 1 |
| Kuyucu, T | 1 |
| Ozyazici, M | 1 |
| Gokce, EH | 1 |
| Ozer, O | 1 |
| Ay, Z | 1 |
| Guneri, T | 1 |
| Ertan, G | 1 |
| Gokce, G | 1 |
| Metin, DY | 1 |
| Hilmioglu, S | 1 |
| Durmaz, G | 1 |
| Yalcin, A | 1 |
| Pekcetin, C | 1 |
| Ozyurt, D | 1 |
| del Palacio-Hernanz, A | 1 |
| Sanz-Sanz, F | 1 |
| Rodriguez-Noriega, A | 1 |
| Gomez-Alvarez, C | 1 |
| Sobel, JD | 10 |
| Muller, G | 5 |
| Rohde-Werner, H | 1 |
| Farkas, B | 1 |
| Simon, N | 1 |
| Donnelly, JP | 1 |
| Starke, ID | 1 |
| Galton, DA | 1 |
| Catovsky, D | 1 |
| Goldman, JM | 1 |
| Darrell, JH | 1 |
| Pfaff, G | 1 |
| Grigoriu, A | 1 |
| Grigoriu, D | 1 |
| Dame, WR | 1 |
| Schweppe, KW | 1 |
| Marks, HJ | 1 |
| Tkach, JR | 1 |
| Rinaldi, MG | 1 |
| Van der Pas, H | 1 |
| Peeters, F | 1 |
| Janssens, D | 1 |
| Snauwaert, E | 1 |
| Smith, AG | 1 |
| Valentová, M | 1 |
| Klobusický, M | 1 |
| Valent, M | 1 |
| Nusch, W | 1 |
| Plempel, M | 1 |
| Bennett, JE | 1 |
| Ryley, JF | 1 |
| Wilson, RG | 1 |
| Barrett-Bee, KJ | 1 |
| Puolakka, J | 1 |
| Tuimala, R | 1 |
| Buckley, HR | 1 |
| Miller, PI | 1 |
| Humphries, M | 1 |
| Grassick, K | 1 |
| Bingham, JS | 2 |
| Kukner, S | 1 |
| Kuscu, E | 1 |
| Ergin, T | 1 |
| Gokmen, O | 1 |
| Schmitt, C | 1 |
| Stein, G | 1 |
| Mummaw, N | 2 |
| Christensen, S | 1 |
| Meriwether, C | 1 |
| Stein, GE | 1 |
| Fong, IW | 3 |
| Bannatyne, RM | 1 |
| Wong, P | 1 |
| White, DJ | 1 |
| Johnson, EM | 1 |
| Warnock, DW | 1 |
| Fortun Abete, J | 1 |
| Hernanz Hermosa, JM | 1 |
| Lázaro Ochaita, P | 1 |
| Pagano, R | 1 |
| Ringdahl, EN | 1 |
| Birinci, A | 1 |
| Saniç, A | 1 |
| Durupinar, B | 1 |
| Shihadeh, AS | 1 |
| Nawafleh, AN | 1 |
| Vasileva, P | 1 |
| Bozhkova, K | 1 |
| Bisschop, MP | 2 |
| Merkus, JM | 4 |
| Scheygrond, H | 2 |
| van de Kuy, A | 1 |
| Tobin, JM | 1 |
| Loo, P | 1 |
| Granger, SE | 1 |
| Roongpisuthipong, A | 2 |
| Sentrakul, P | 1 |
| Bhiraleus, P | 2 |
| Dusitsin, N | 1 |
| Sukroongreung, S | 2 |
| Pupaibul, K | 1 |
| Laufer, B | 1 |
| Bender, HG | 1 |
| Mazziotti, F | 1 |
| Cirillo, L | 1 |
| Arena, V | 1 |
| Cipriani, P | 1 |
| Ghezzi, C | 1 |
| Bresadola, M | 1 |
| Ragni, N | 1 |
| Donadio, C | 1 |
| Pellizzari, G | 1 |
| Jansen, TM | 1 |
| Van de Ven, MA | 1 |
| Borgers, MJ | 1 |
| Odds, FC | 1 |
| Van Cutsem, JM | 1 |
| Baraggino, E | 2 |
| Orsetti, G | 1 |
| Ribaric, G | 1 |
| Wiesenfeld, V | 1 |
| Pecorari, D | 1 |
| Silva-Cruz, A | 2 |
| Andrade, L | 2 |
| Sobral, L | 1 |
| Francisca, A | 1 |
| Sharma, JB | 1 |
| Buckshee, K | 1 |
| Gulati, N | 1 |
| Varga, A | 1 |
| Lovas, J | 1 |
| Wesel, S | 1 |
| Van Heusden, AM | 2 |
| Kovacs, GT | 1 |
| Westcott, M | 1 |
| Rusden, J | 1 |
| Bottino, G | 1 |
| Menna, C | 1 |
| Salem, HT | 1 |
| Salah, M | 1 |
| Farid, A | 1 |
| Sabra, AM | 1 |
| Makarem, MH | 1 |
| Gerhard, I | 1 |
| Ohlhorst, D | 1 |
| Eggert-Kruse, W | 1 |
| Runnebaum, B | 1 |
| Bloch, B | 2 |
| Barnard, PG | 1 |
| Burger, GD | 1 |
| Meyer, JS | 1 |
| Parkes, JR | 1 |
| Smythe, E | 2 |
| Silva Cruz, A | 1 |
| Oliveira, JE | 1 |
| Sobral, JL | 1 |
| Cauwenbergh, G | 1 |
| Borghys, AM | 1 |
| Dupré, K | 1 |
| Mariën, K | 1 |
| Degreef, H | 1 |
| Brammer, KW | 3 |
| Feczko, JM | 1 |
| Kutzer, E | 1 |
| Oittner, R | 1 |
| Leodolter, S | 1 |
| Richardson, K | 1 |
| Marriott, MS | 1 |
| Troke, PF | 1 |
| Palmer, GC | 1 |
| Ordy, JM | 1 |
| Simmons, RD | 1 |
| Strand, JC | 1 |
| Mullen, GB | 1 |
| Kinsolving, CR | 1 |
| St Georgiev, V | 1 |
| Allen, SD | 1 |
| Robertson, WH | 1 |
| Garamvölgyi, G | 1 |
| Pajor, A | 1 |
| Lintner, F | 1 |
| Lüscher, KP | 1 |
| Schneitter, J | 1 |
| Vogt, HP | 1 |
| Orsetti, GM | 1 |
| Azzaroni, L | 1 |
| Petranyi, G | 1 |
| Mieth, H | 1 |
| Karsay, K | 1 |
| Kovács, I | 1 |
| Somos, P | 1 |
| Hámori, M | 1 |
| Verö, T | 1 |
| Adám, J | 1 |
| Ba, J | 1 |
| O'Connor, MI | 1 |
| van der Meijden, WI | 1 |
| van der Hoek, JC | 1 |
| Staal, HJ | 1 |
| van Joost, T | 1 |
| Stolz, E | 1 |
| Zlatkov, V | 1 |
| Karag'ozov, I | 1 |
| Difonzo, EM | 1 |
| Palleschi, GM | 1 |
| Vannini, P | 1 |
| Panconesi, E | 1 |
| Chaisilwattana, P | 1 |
| Patanapanich, P | 1 |
| Bhadrakom, C | 1 |
| Ichise, K | 1 |
| Tanio, T | 1 |
| Saji, I | 1 |
| Okuda, T | 1 |
| Kinsman, OS | 1 |
| Collard, AE | 1 |
| Savage, TJ | 1 |
| Tallián, F | 1 |
| Eschenbach, DA | 1 |
| Hummel, D | 1 |
| Gravett, MG | 1 |
| Duarte, V | 1 |
| Hauser, GA | 1 |
| McCormick, JF | 1 |
| Monif, GR | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase IIa Randomized, Active-controlled, Double-blind, Dose-escalation Study in Patients With Vulvovaginal Candidiasis to Evaluate Dose Response Relationship of Clinical Efficacy, Safety and Tolerability of Topically Administered ProF-001[NCT03115073] | Phase 2/Phase 3 | 84 participants (Actual) | Interventional | 2017-04-04 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for ketoconazole and Candidiasis, Genital
| Article | Year |
|---|---|
Vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Fe | 2002 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Itraconazole; | 2003 |
Candidiasis (vulvovaginal).
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazol | 2005 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Cand | 1995 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Chil | 1995 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; | 2000 |
[Current developments in antimycotic therapy in gynecology and obstetrics].
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Flu | 1992 |
[Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis].
Topics: Adult; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle | 1992 |
[Preliminary clinical study of the use of itraconazole in the treatment of vulvovaginal candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Humans; Itraconazole; | 1991 |
Chronic vulvovaginal candidosis: the role of oral treatment.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; | 1990 |
Fluconazole and itraconazole for vulvo-vaginal candidosis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Itraconazole; Ketoconazol | 1990 |
33 trials available for ketoconazole and Candidiasis, Genital
| Article | Year |
|---|---|
Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Chitosan; Drug Compounding; D | 2019 |
Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences.
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; | 2013 |
Exploratory study on the clinical and mycological effectiveness of a herbal medicinal product from Solanum chrysotrichum in patients with Candida yeast-associated vaginal infection.
Topics: Administration, Topical; Adolescent; Adult; Antifungal Agents; Candida; Candida albicans; Candidiasi | 2009 |
[Evaluation of efficacy of ketoconazole 800 mg-clindamycin 100 mg tablets vaginal against ketoconazole 800 mg- clindamycin 100 mg vaginal capsules in candida vaginitis and vaginosis].
Topics: Actinomycetales Infections; Administration, Intravaginal; Adolescent; Adult; Candida albicans; Candi | 2011 |
Vulvovaginal candidiasis in children and adolescents with type 1 diabetes mellitus.
Topics: Adolescent; Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Child; Child, Preschool; D | 2004 |
Ketoconazole in vulvovaginal candidosis.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Ketoconazole | 1984 |
Topical tioconazole versus systemic ketoconazole treatment of vaginal candidiasis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Antifungal Agents; Candidiasis, Vu | 1984 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Adolescent; Adult; Amphotericin B; Antineoplastic Agents; Candidiasis, Oral; Candidiasis, Vulvovagin | 1984 |
Comparison between oral ketoconazole and topical miconazole in the treatment of vaginal candidiasis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinica | 1983 |
A single-blind comparison of oral and intravaginal treatments in acute and recurrent vaginal candidosis in general practice.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; | 1984 |
Single blind comparison of ketoconazole 200 mg oral tablets and clotrimazole 100 mg vaginal tablets and 1% cream in treating acute vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Candidiasis, Vulvovaginal; Clinica | 1984 |
Vaginal thrush and its management in pregnancy.
Topics: Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Microscopy, Phase-Contrast; Pakistan; Pregn | 1995 |
Initial management of recurrent vulvovaginal candidiasis with oral ketoconazole and topical clotrimazole.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candidiasis, V | 1994 |
Placebo-controlled trial of itraconazole for treatment of acute vaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Double-Blind Method; Female; Huma | 1993 |
Lack of in vitro resistance of Candida albicans to ketoconazole, itraconazole and clotrimazole in women treated for recurrent vaginal candidiasis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Clotrimazol | 1993 |
The value of treating the male partner in vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Chi-Square Distribution; Dose-Response Relat | 2000 |
Treatment of vaginal candidosis: a comparative study of the efficacy and acceptability of itraconazole and clotrimazole.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; Ket | 1992 |
The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Itraconazole; | 1992 |
[Comparative clinical study of a new imidazole molecule (fluconazole) and ketaconazole in the treatment of Candida albicans vulvovaginitis].
Topics: Adult; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle | 1992 |
The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Male; Recurren | 1992 |
[Preliminary clinical study of the use of itraconazole in the treatment of vulvovaginal candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Humans; Itraconazole; | 1991 |
Itraconazole versus placebo in the management of vaginal candidiasis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Drug Evaluation; Female; H | 1991 |
Comparison of topical fungicides in women suffering from vulvovaginitis.
Topics: Administration, Intravaginal; Administration, Oral; Candidiasis, Vulvovaginal; Clotrimazole; Female; | 1991 |
Itraconazole: a single-day oral treatment for acute vulvovaginal candidosis.
Topics: Acute Disease; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; I | 1990 |
Oral versus local treatment of vaginal candidosis.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Mi | 1989 |
[Topical one-time therapy with ketoconazole: a double-blind randomized study in vaginal mycosis].
Topics: Administration, Intravaginal; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Bli | 1989 |
Itraconazole in the treatment of acute vaginal candidiasis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Evaluation; Female; Humans; It | 1988 |
An open assessment of three different treatment regimens of itraconazole for the management of vaginal candidosis.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Itraconazole; Ketoc | 1988 |
Single-dose oral fluconazole in the treatment of vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clinica | 1988 |
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinica | 1988 |
Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Female; | 1986 |
Double-blind comparison of 200-mg ketoconazole oral tablets and 1200-mg miconazole vaginal capsule in the treatment of vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Candidiasis, Vulvovaginal; Clinical Trials as Topic; | 1986 |
Recurrent vulvovaginal candidiasis. A prospective study of the efficacy of maintenance ketoconazole therapy.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Drug Administratio | 1986 |
64 other studies available for ketoconazole and Candidiasis, Genital
| Article | Year |
|---|---|
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida; Candidiasis, Vulvovaginal; Cryptococcus | 1984 |
Derivatives of a novel cyclopeptolide. 1. Synthesis, antifungal activity, and structure-activity relationships.
Topics: Administration, Oral; Amino Acid Sequence; Animals; Antifungal Agents; Candida; Candidiasis, Vulvova | 1994 |
Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes.
Topics: Adult; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Cluster Ana | 2009 |
A rare fungal infection of infants: a diffuse case of mucocutaneous candidiasis.
Topics: Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Female; Humans; Infant, Newbor | 2020 |
Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
Topics: Animals; Antifungal Agents; Benzylisoquinolines; Candida albicans; Candidiasis, Vulvovaginal; Colony | 2010 |
[Nizoral - an effective and affordable drug to treat vaginal candidiasis ].
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole | 2009 |
In vitro release--in vivo microbiological and toxicological studies on ketoconazole lipid granules.
Topics: Aluminum Hydroxide; Animals; Antacids; Antifungal Agents; Candida albicans; Candidiasis, Vulvovagina | 2007 |
Vulvovaginal candidiasis--what we do and do not know.
Topics: Candidiasis, Vulvovaginal; Chronic Disease; Female; Humans; Ketoconazole; Recurrence | 1984 |
Comparison of itraconazole and ketoconazole in the treatment of experimental candidal vaginitis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Itraconazole; Ketoconazole; Rats; Rat | 1984 |
[Comparative study of an orally and a locally administered antifungal agent in vaginal mycoses].
Topics: Administration, Oral; Adult; Candida; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Micon | 1984 |
Ketoconazole--an antifungal drug for oral use.
Topics: Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Keto | 1981 |
[Research in the treatment of fungal infections].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Humans; Imidazoles; Ketoconazo | 1982 |
Superficial mycoses: ketoconazole treatment.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Child; Dermat | 1982 |
[Experiences with the oral antimycotic ketoconazole in vaginal fungal involvement].
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Human | 1982 |
The antifungal activity of ketoconazole.
Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, | 1983 |
[Oral treatment of chronic recurring vaginal candidiasis with Nizoral].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Evaluation; F | 1983 |
Treatment of vaginal candidiasis with ketoconazole.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Ketoconazole; Piper | 1983 |
Treatment of vaginal candidosis with oral ketoconazole.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Child; Female; Humans; Imidazole | 1983 |
Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Imidazoles; Ketoconazole; Rats; Rats, | 1983 |
Potentiation of oral anticoagulants by ketoconazole.
Topics: Aged; Candidiasis, Vulvovaginal; Contusions; Drug Synergism; Female; Humans; Ketoconazole; Pulmonary | 1984 |
[Oral antimycotic ketoconazole in the treatment of vaginal mycoses].
Topics: Administration, Oral; Balanitis; Candidiasis; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazol | 1984 |
[Microbiological determination of the oral antifungal agent Bay N 7133 and ketoconazole in cervical and vaginal secretion of patients].
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Assay; Candida; Candidiasis, Vulvovaginal | 1983 |
Assessing response to therapy for mucosal candidiasis.
Topics: Candida albicans; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Female; Humans; Ketocon | 1984 |
Azole resistance in Candida albicans.
Topics: Amino Acids; Animals; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Candi | 1984 |
Ketoconazole in the prevention of experimental candidal vaginitis.
Topics: Animals; Candidiasis, Vulvovaginal; Castration; Female; Ketoconazole; Ovary; Rats; Rats, Inbred Stra | 1984 |
Critical role of germ tube formation in the pathogenesis of candidal vaginitis.
Topics: Adhesiveness; Adult; Animals; Candida albicans; Candidiasis, Vulvovaginal; Endothelium; Female; Huma | 1984 |
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; | 1993 |
Vulvar vestibulitis syndrome: an often unrecognized cause of dyspareunia.
Topics: Adolescent; Adult; Aged; Amitriptyline; Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; | 1999 |
Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; | 2001 |
[Vulvovaginal candidiasis in childhood--diagnostic and therapeutic results].
Topics: Adolescent; Anti-Bacterial Agents; Antifungal Agents; Bulgaria; Candidiasis, Vulvovaginal; Child; Ch | 2001 |
Treatment of vaginal candidiasis with ketoconazole, a new, orally active, antimycotic.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Hu | 1979 |
Itraconazole in the treatment of acute vaginal candidosis.
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Itra | 1992 |
Fungal morphology after treatment with itraconazole as a single oral dose in experimental vaginal candidosis in rats.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Femal | 1991 |
Oral ketoconazole and miconazole vaginal pessary treatment for vaginal candidosis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Follow-Up | 1991 |
Chronic recurrent vaginal candidosis: easy to treat, difficult to cure. Results of intermittent treatment with a new oral antifungant.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Drug Adm | 1990 |
A prospective study to assess the efficacy of ketoconazole in the treatment of recurrent vaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Consumer Behavior; Female; Human | 1990 |
[Comparison of fluconazole and ketoconazole in the therapy of vaginal candidiasis by administration in two different oral doses].
Topics: Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Drug Evaluation; Female; Fluconazole; H | 1990 |
Experience with itraconazole in treatment of fungal infections.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Drug Evaluation; Female; Humans; Itrac | 1987 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; | 1985 |
Comparisons of ketoconazole, PR 969-566, PR 967-234, and PR 967-248 as antifungals in vitro and in the rat model of candidal vaginitis based on efficacy/safety profiles.
Topics: Animals; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Disease Models, Animal; Female; Fung | 1988 |
Mycology of vulvovaginitis.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Co | 1988 |
Importance of oral ketoconazole in family planning especially in women using intra-uterine device.
Topics: Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral; Family Pla | 1988 |
[Incidence of Candida infections during pregnancy and their treatment with ketoconazole-ovula].
Topics: Administration, Intravaginal; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Pregnancy; Pr | 1987 |
[Systemic treatment with ketoconazole in vulvovaginal candidiasis].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; | 1987 |
Activity of terbinafine in experimental fungal infections of laboratory animals.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Dermatomycoses; Female; Guinea | 1987 |
New therapeutic means (Nizoral) in the treatment of vaginal mycoses.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral; Drug Interactions; Female; Human | 1987 |
Examination of the potential interaction between ketoconazole (Nizoral) and oral contraceptives with special regard to products of low hormone content (Rigevidon, anteovin).
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Contraceptives, Oral, Hormonal; Contraceptives, Postco | 1986 |
Comparative study of local and oral treatment of vaginal candidiasis (Canesten-Nizoral).
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Candidiasis, Vulvovaginal; Cl | 1987 |
Treatment of vaginal discharge caused by blastomycetes with nizoral tablet.
Topics: Adolescent; Adult; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Ketoconazole; Leukorrhea | 1986 |
Vulvo-vaginal candidosis--an overview.
Topics: Candidiasis, Vulvovaginal; Coitus; Diabetes Complications; England; Epidemiologic Methods; Female; H | 1986 |
Epidemiology of recurrent vulvovaginal candidiasis: identification and strain differentiation of Candida albicans.
Topics: Candida albicans; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Male; Mouth; Penis; Rectu | 1986 |
[Initial impressions from using the new oral antimycotic Nizoral].
Topics: Administration, Oral; Candidiasis, Vulvovaginal; Chronic Disease; Drug Evaluation; Female; Humans; K | 1987 |
Therapeutic experience with ketoconazole.
Topics: Candidiasis, Vulvovaginal; Dermatomycoses; Female; Humans; Ketoconazole; Sporotrichosis; Tinea | 1986 |
Treatment of vaginal candidosis with oral ketoconazole.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Middle Aged | 1986 |
Activity of SM-4470, a new imidazole derivative, against experimental fungal infections.
Topics: Animals; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Vulvovaginal; Female; Guinea Pi | 1986 |
Ketoconazole in experimental vaginal candidosis in rats.
Topics: Animals; Candidiasis, Vulvovaginal; Estrogens; Female; Ketoconazole; Rats; Vagina | 1986 |
Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis.
Topics: Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; M | 1985 |
Oral treatment of vaginal mycoses with Nizoral tablet.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole | 1985 |
Recurrent and persistent vulvovaginal candidiasis: treatment with ketoconazole.
Topics: Adult; Bacteriological Techniques; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Middle A | 1985 |
The management of genital candidosis with an oral antimycotic agent, ketoconazole.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Contracep | 1986 |
Ketoconazole in the treatment of vaginal candidiasis.
Topics: Administration, Oral; Adult; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole; Pilot Projects | 1985 |
[Oral therapy of vaginal candidiasis with ketoconazole].
Topics: Administration, Oral; Candidiasis, Vulvovaginal; Female; Humans; Ketoconazole | 1985 |
Experimental chronic vaginal candidosis in rats.
Topics: Animals; Candidiasis, Vulvovaginal; Disease Models, Animal; Female; Ketoconazole; Rats; Rats, Inbred | 1985 |
Classification and pathogenesis of vulvovaginal candidiasis.
Topics: Anti-Bacterial Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Ketoconazole; Risk; | 1985 |